Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy.
about
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemiaRQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemia.WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
P2860
Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Usefulness of quantitative ass ...... s undergoing imatinib therapy.
@ast
Usefulness of quantitative ass ...... s undergoing imatinib therapy.
@en
type
label
Usefulness of quantitative ass ...... s undergoing imatinib therapy.
@ast
Usefulness of quantitative ass ...... s undergoing imatinib therapy.
@en
prefLabel
Usefulness of quantitative ass ...... s undergoing imatinib therapy.
@ast
Usefulness of quantitative ass ...... s undergoing imatinib therapy.
@en
P356
P1476
Usefulness of quantitative ass ...... s undergoing imatinib therapy.
@en
P2093
Daniela Cilloni
Giuseppe Saglio
P356
10.1053/SHEM.2003.50040
P433
P577
2003-04-01T00:00:00Z